GlassScriptPhysician profile
Courtney Chambers
NPI 1669929782
$466.51
in general payments reported to CMS, 2019-2025
18 companies · $150 in 2025
The $150 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $57.56 · 2022: $57.36 · 2023: $111 · 2024: $90.52 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $351.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $75.65 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $59.75 | 2023-2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $43.27 | 2024 | Verquvo |
| Agile Therapeutics, INC. | $28.86 | 2022 | |
| Urovant Sciences INC | $28.62 | 2021-2022 | |
| Boston Scientific Corporation | $25.60 | 2025 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $25.59 | 2025 | |
| Ethicon US, LLC | $24.35 | 2023 | Surgicel Nu-Knit |
| Astellas Pharma US INC | $22.79 | 2025 | Veozah |
| Sage Therapeutics, LLC | $18.93 | 2025 | Zurzuvae |
| Millicent US INC | $18.01 | 2025 | Femlyv, Intrarosa |
| Janssen Biotech, INC. | $15.94 | 2024 | Tremfya |
| Exeltis, USA INC. | $15.27 | 2023 | Slynd |
| Regeneron Healthcare Solutions, INC. | $15.00 | 2023 | Evkeeza |
| Organon LLC | $14.04 | 2025 | Nexplanon |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $13.38 | 2023 | Otezla, Enbrel |
| Kiniksa Pharmaceuticals International, Plc | $13.10 | 2024 | Arcalyst |
| Kerecis Limited | $8.36 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Courtney Chambers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.